Handelsavisen
prelaunch
Companies Healthcare ALPS.O
AL
ALPS.O NASDAQ Healthcare Facilities & Services

Alps Group Inc

$0,40
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
ROE
Net margin
Debt / equity
Beta
52w range
Volume
Day range
Prev close
$0,73
Open
Next earnings
Ex-dividend
TR 1Y
About

Alps Group Inc operates in the healthcare sector, focusing on pharmaceuticals and healthcare facilities and services.

Business. Alps Group Inc (ALPS.O) is a healthcare company operating within the Healthcare Facilities & Services industry, with primary activities in pharmaceuticals. The firm generates revenue through service-based models typical of the healthcare services and equipment sector. Alps Group Inc is listed on the NASDAQ exchange. Specific details regarding operating segments, headquarters location, and geographic mix are not available in the provided data.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityPharmaceuticals
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
UBS Financial Services, Inc.
largest disclosed fund holder
Profitability
not yet wired
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning ALPS.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to ALPS.O. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Alps Group Inc (ALPS.O) is a healthcare company operating within the Healthcare Facilities & Services industry, with primary activities in pharmaceuticals. The firm generates revenue through service-based models typical of the healthcare services and equipment sector. Alps Group Inc is listed on the NASDAQ exchange. Specific details regarding operating segments, headquarters location, and geographic mix are not available in the provided data.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityPharmaceuticals
    AI synthesis
    GENERATED

    Alps Group Inc has a basic and diluted share count of 172,435,326 shares outstanding, indicating no immediate dilution pressure from share-based compensation or convertible instruments. However, the company's liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.

    Profitability and return metrics for Alps Group Inc are not available in the valuation snapshot, making it difficult to compare its performance against industry_config preferred metrics or cohort medians. Without these metrics, an assessment of its operational efficiency and capital returns is not possible at this time.

    Segment and geographic exposure data for Alps Group Inc are not disclosed in the available financial reports, which limits the ability to assess revenue concentration or geographic diversification. This lack of detail prevents a comprehensive evaluation of the company's exposure to regional economic conditions or market-specific risks.

    Growth trajectory data for Alps Group Inc is not available in the outlook section, and historical revenue data is insufficient to determine a clear growth pattern. Without numeric deltas or revenue history, it is not possible to project the company's future performance or assess its growth potential.

    Risk factors for Alps Group Inc include the inability to assess liquidity risk due to missing balance-sheet data and the absence of going-concern language in source documents. The company's dilution potential is currently low, as there is no evidence of share-based compensation or convertible instruments affecting the share count.

    Recent events and filings for Alps Group Inc do not provide additional insights into the company's operations or strategic direction. The lack of detailed disclosures in recent filings or transcripts limits the ability to identify material developments or management commentary that could impact the company's future performance.

    Key takeaways
    • Alps Group Inc operates in the healthcare sector with a focus on pharmaceuticals and healthcare facilities and services.
    • The company has no immediate dilution pressure, as basic and diluted share counts are equal.
    • Liquidity risk could not be assessed due to missing balance-sheet data and no going-concern language in source documents.
    • Profitability and return metrics are not available, making it difficult to compare performance against industry benchmarks.
    • Segment and geographic exposure data are not disclosed, limiting the ability to assess revenue concentration or geographic diversification.
    • Growth trajectory and historical revenue data are insufficient to determine a clear growth pattern.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $0,40
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    Net cash
    Current ratio
    Debt / equity
    ROA
    ROE
    Cash conversion
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskUnknown

    Benchmarks vs cohort

    No cohort benchmark data available for this issuer yet.

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    Source documents
    • Alps Group Inc Market data — financials · 2026-05-27

    Ownership & reference

    Top holders

    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$0M

    Insider activity

    — missing data

    Short positioning

    31.1Kshares short+117.9% vs prior
    1days to cover
    4.4%short of daily vol
    778fails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    ALPS.OCanonical
    NASDAQ · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskUnknown

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-07-29 22:34 UTCEVENTHa Price Listing ALPS remains DEFICIENT (NASDAQ) — cure period. closed below $1.00 for 69 consecutive trading days (last close $0.5). cure deadline 2027-01-17 (172 days remaining).
    2026-06-30 00:00 UTCTRANSCRIPTEarnings call — Q2 2026
    2026-06-30 00:00 UTCEARNINGSUpcomingEarnings scheduled →
    2026-06-30EVENTQ2 2026 earnings (expected) estimated date
    2026-06-09FILING6-K filing →
    2026-05-19FILING6-K filing →
    2026-04-17FILING6-K filing →
    2026-02-23FILING6-K filing →
    2026-02-05FILING6-K filing →
    2026-01-30FILING6-K filing →
    2026-01-21FILING424B3 filing →
    2026-01-08FILING6-K filing →
    2025-10-31FILING20-F filing →
    2025-10-30FILING6-K filing →
    2025-10-10FILING6-K filing →
    2025-09-17FILING424B3 filing →
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage